Emergency management of pediatric skin and soft tissue infections in the community-associated methicillin-resistant Staphylococcus aureus era
- PMID: 20370748
- DOI: 10.1111/j.1553-2712.2009.00652.x
Emergency management of pediatric skin and soft tissue infections in the community-associated methicillin-resistant Staphylococcus aureus era
Abstract
Objectives: Skin and soft tissue infections (SSTIs) are increasing in incidence, yet there is no consensus regarding management of these infections in the era of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). This study sought to describe current pediatric emergency physician (PEP) management of commonly presenting skin infections.
Methods: This was a cross-sectional survey of subscribers to the American Academy of Pediatrics Section on Emergency Medicine (AAP SoEM) list-serv. Enrollment occurred via the list-serv over a 3-month period. Vignettes of equivocal SSTI, cellulitis, and skin abscess were presented to participants, and knowledge, diagnostic, and therapeutic approaches were assessed.
Results: In total, 366 of 606 (60.3%) list-serv members responded. The mean (+/- standard deviation [SD]) duration of practice was 13.6 (+/-7.9) years, and 88.6% practiced in a pediatric emergency department. Most respondents (72.7%) preferred clinical diagnosis alone for equivocal SSTI, as opposed to invasive or imaging modalities. For outpatient cellulitis, PEPs selected clindamycin (30.6%), trimethoprim-sulfa (27.0%), and first-generation cephalosporins (22.7%); methicillin-sensitive S. aureus (MSSA) was routinely covered, but many regimens failed to cover CA-MRSA (32.5%) or group A streptococcus (27.0%). For skin abscesses, spontaneous discharge (67.5%) was rated the most important factor in electing to perform a drainage procedure; fever (19.9%) and patient age (13.1%) were the lowest. PEPs elected to prescribe trimethoprim-sulfamethoxazole (TMP-Sx; 50.0%) or clindamycin (32.7%) after drainage; only 5% selected CA-MRSA-inactive agents. All PEPs suspected CA-MRSA as the etiology of skin abscesses, and many attributed sepsis (22.1%) and invasive pneumonia (20.5%) to CA-MRSA, as opposed to MSSA. However, 23.9% remained unaware of local CA-MRSA prevalence for even common infections.
Conclusions: Practice variation exists among PEPs for management of SSTI. These results can be used to measure changes in SSTI practices as standardized approaches are delineated.
(c) 2010 by the Society for Academic Emergency Medicine.
Similar articles
-
Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.J Emerg Med. 2012 Apr;42(4):392-9. doi: 10.1016/j.jemermed.2011.03.009. Epub 2011 Apr 27. J Emerg Med. 2012. PMID: 21524884
-
The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.Am J Ther. 2009 Jul-Aug;16(4):333-8. doi: 10.1097/MJT.0b013e31817fdea8. Am J Ther. 2009. PMID: 19617720
-
Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.Pediatrics. 2009 Jun;123(6):e959-66. doi: 10.1542/peds.2008-2428. Epub 2009 May 26. Pediatrics. 2009. PMID: 19470525
-
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections.Curr Opin Pediatr. 2010 Jun;22(3):273-7. doi: 10.1097/MOP.0b013e328339421b. Curr Opin Pediatr. 2010. PMID: 20386450 Review.
-
Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S368-77. doi: 10.1086/533593. Clin Infect Dis. 2008. PMID: 18462092 Review.
Cited by
-
Clinical management of skin and soft tissue infections in the U.S. Emergency Departments.West J Emerg Med. 2014 Jul;15(4):491-8. doi: 10.5811/westjem.2014.4.20583. West J Emerg Med. 2014. PMID: 25035757 Free PMC article.
-
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.Paediatr Drugs. 2021 Nov;23(6):549-563. doi: 10.1007/s40272-021-00468-w. Epub 2021 Aug 31. Paediatr Drugs. 2021. PMID: 34462863 Free PMC article. Review.
-
Testing and Treatment Thresholds for Pediatric Pneumonia in the Emergency Department.Hosp Pediatr. 2024 Dec 1;14(12):992-1000. doi: 10.1542/hpeds.2024-007848. Hosp Pediatr. 2024. PMID: 39558750
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous